Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 26, 2018
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
[ Mon, Feb 26th 2018
] - WOPRAI
Fri, February 23, 2018
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
[ Fri, Feb 23rd 2018
] - WOPRAI
Andrew Peters Maintained (BMRN) at Strong Buy with Increased Target to $124 on, Feb 23rd, 2018
Published on 2024-10-26 03:17:44 -
Andrew Peters of Deutsche Bank, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $119 to $124 on, Feb 23rd, 2018.
Andrew has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $129 on, Wednesday, January 24th, 2018
- Liana Moussatos of "Wedbush" Upgraded from Hold to Buy on, Thursday, December 14th, 2017
Similar Stocks and Investing Articles
[ Wed, Feb 14th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Tue, Feb 07th 2017
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Fri, Oct 02nd 2015
] - WOPRAI
[ Wed, Aug 05th 2015
] - WOPRAI
[ Tue, Aug 04th 2015
] - WOPRAI
[ Thu, Jul 24th 2014
] - WOPRAI
[ Mon, Nov 05th 2012
] - WOPRAI
[ Thu, Sep 27th 2012
] - WOPRAI